Table 2.

Patient information of the control group

Patient No.	Age (yr)	Sex	BP	Reason for BP use	Follow-up point (mo)	Defect area (mm2)
1	77	F	Unknown BP	Osteoporosis	12	178.37
2	83	F	Alendronate	Osteoporosis	6	1,073.87
3	67	F	Alendronate	Osteoporosis	6	186.16
4	76	F	Alendronate	Osteoporosis	6	336.88
5	74	F	Alendronate	Osteoporosis	6	79.79
6	63	F	Unknown BP	Osteoporosis	10	236.37
7	83	F	Alendronate, ibandronate	Osteoporosis	6	145.72
8	76	F	Alendronate	Osteoporosis	6	617.60

(BP: bisphosphonate, F: female)